Terminology Service for NFDI4Health
All terms in CHEBI
| Label | Id | Description |
|---|---|---|
| Actinamine | CHEBI_81195 | |
| 3-Keto-scyllo-inosamine | CHEBI_81196 | |
| myo-Inosose-5 | CHEBI_81197 | |
| neo-Inosamine-2 | CHEBI_81198 | |
| 2-Methyl-6-solanyl-1,4-benzoquinol | CHEBI_81191 | |
| Bluensidine 6-phosphate | CHEBI_81192 | |
| Bluensomycin | CHEBI_81193 | |
| 2-epi-Streptamine | CHEBI_81194 | |
| 5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl hydrogen sulfate | CHEBI_4734 | [An aryl sulfate obtained by sulfation of the phenolic hydroxy group of the anti-inflammatory drug, E3040. It is one of the major metabolites of E3040.] |
| 5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl sulfate(1-) | CHEBI_144583 | [An aryl sulfate oxoanion that is the conjugate base of 5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl hydrogen sulfate, obtained by deprotonation of the sulfo group; major species at pH 7.3.] |
| E3040 | CHEBI_4732 | [A member of the class of benzothiazoles that is 1,3-benzothiazole substituted by a methylnitrilo group, (pyridin-3-yl)methyl group, methyl group, hydroxy group and methyl group at position 2,4,5,6 and 7, respectively. It is a dual inhibitor of 5-lipoxygenase and thromboxane A2 synthetase and exhibits anti-inflammatory properties. The drug was being developed by Eisai (Tokyo, Japan) for the treatment of bowel disease.] |
| N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide | CHEBI_124480 | |
| CHEBI_4735 | CHEBI_4735 | |
| N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide | CHEBI_124481 | |
| N-[(2S,3S)-2-[[[(1,3-benzodioxol-5-ylamino)-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-oxanecarboxamide | CHEBI_124482 | |
| N-ethylphenylacetamide | CHEBI_4737 | [A monocarboxylic acid amide obtained by formal condensation of the carboxy group of phenylacetic acid with the amino group of ethylamine.] |
| N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-tetrazolyl)acetamide | CHEBI_124483 | |
| CHEBI_4730 | CHEBI_4730 | |
| 4-chloro-N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide | CHEBI_124484 | |
| CHEBI_4731 | CHEBI_4731 |